Keyphrases
Abrogation
11%
Binding Protein
100%
Breast Cancer Cell Migration
11%
Cell Surface
33%
Cell-based
11%
Chemotherapy
100%
Chemotherapy Regimen
11%
Chemotherapy-induced
11%
CRISPR-Cas9 Technology
11%
Cyclic Adenosine Monophosphate (cAMP)
100%
Doxorubicin
11%
Glucose-regulated Protein 78 (GRP78)
100%
In Vitro Assay
11%
Inoculation
11%
Master Regulator
11%
Metastasis
100%
Metastasis Suppressor
11%
Metastatic Breast Cancer
33%
Metastatic Cascade
11%
Metastatic Disease
11%
Metastatic Models
11%
Metastatic Mouse Model
11%
Metastatic Potential
11%
Metastatic Triple-negative Breast Cancer
11%
Migration Potential
11%
Molecular Drivers
11%
Novel Treatments
11%
Paclitaxel
11%
Responsive Element
100%
Stimulatory Effect
100%
Targeted Drugs
11%
Transcription Factor
100%
Triple Negative
11%
Triple-negative Breast Cancer Cells
22%
Tumor Cells
11%
Unfolded Protein Response
33%
Medicine and Dentistry
Breast Cancer
37%
Cancer Cell
37%
Cas9
12%
Cell Line
12%
Cell Migration
12%
Cell Surface
37%
Chemotherapy Regimens
12%
Clustered Regularly Interspaced Short Palindromic Repeat
12%
Cyclic AMP
12%
Cyclic AMP Responsive Element Binding Protein
100%
Doxorubicin
12%
Glucose Regulated Protein 78
100%
In Vitro
12%
Metastasis Potential
12%
Metastasis Suppressor
12%
Metastatic Breast Cancer
12%
Metastatic Carcinoma
100%
Paclitaxel
12%
Synapsin II
100%
Transcription Factors
100%
Triple Negative Breast Cancer
25%
Tumor Cell
12%
Unfolded Protein Response
37%
Pharmacology, Toxicology and Pharmaceutical Science
Breast Cancer
37%
Chemotherapy
100%
Chemotherapy Regimens
12%
Cyclic AMP
12%
Cyclic AMP Responsive Element Binding Protein
100%
Doxorubicin
12%
Glucose Regulated Protein 78
100%
Metastasis
37%
Metastasis Potential
12%
Metastatic Breast Cancer
12%
Mouse
12%
Mouse Model
12%
Neoplasm
12%
Paclitaxel
12%
Synapsin II
100%
Transcription Factors
100%
Triple Negative Breast Cancer
25%